VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/29/2026

1. SPY
2. CDNS
3. NVDA
4. META
5. FFIV
6. AAPL
7. USO
8. TFII
9. XFLT
10. AMZN

Go back to VERAXA Biotech advances VXA-222 bispecific ADC program with OmniAb
(NASDAQ: OABI) Delayed: 1.97 -0.06 (2.96%)
Previous Close $2.03    52 Week High $ 
Open $2.04    52 Week Low $ 
Day High $2.10    P/E N/A 
Day Low $1.95    EPS $ 
Volume 312,952       

(NASDAQ: VRXA) Delayed: 1.98 -0.03 (1.49%)
Previous Close $2.01    52 Week High $ 
Open $2.05    52 Week Low $ 
Day High $2.10    P/E N/A 
Day Low $1.86    EPS $ 
Volume 312,454